AVBP vs BHVN Stock Comparison
BHVN currently leads AVBP in this stock comparison, with AIQ scores of 47 vs 35. The clearest difference is momentum, while AVBP has the stronger quality profile.
What is the main difference between AVBP and BHVN?
BHVN leads the current stock comparison as Biohaven Ltd., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
ArriVent BioPharma, Inc. vs Biohaven Ltd.
BHVN leads
BHVN leads by 12 AIQ points, primarily on Momentum, having only recently taken the lead back from AVBP.
Fragile: 3 of 5 evidence groups support BHVN, the lead recently changed hands, and its current signal state is conflicted.
ArriVent BioPharma, Inc.
Biohaven Ltd.
The Algovestiq AIQ Score currently favors BHVN over AVBP, 47 versus 35 as of Nov 15, 2026. BHVN's advantage is driven primarily by stronger momentum, while AVBP holds the stronger quality profile. BHVN also shows the stronger technical structure relative to its 50-day moving average. 3 of 5 covered evidence groups favor BHVN today, and the comparison is rated Fragile on stability: the lead has already changed hands inside the comparison window. BHVN lead: Reversed — AVBP led by 5 AIQ points 30 sessions ago; BHVN now leads by 12.
Compare ArriVent BioPharma, Inc. and Biohaven Ltd. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare AVBP and BHVN against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum23 vs 78BHVN +55
- Quality51 vs 16AVBP +35
- Risk Resilience32 vs 35Even
3 of 5 evidence groups favor BHVN. BHVN’s edge is concentrated in momentum; AVBP keeps a meaningful quality edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Quality +7
No signal started or stopped since the prior session; its 4 active signals are unchanged.
Largest factor move: Momentum +1
New signals
- ADX Trend Weakening — neutral, trend, medium horizon
BHVN's lead narrowed by 2 AIQ points in the latest session.
Deeper signal detail for each name lives on its own signals page — AVBP and BHVN both carry a full feed there.
The central trade-off
BHVN (Biohaven Ltd.): the stronger current systematic profile, led by momentum.
AVBP (ArriVent BioPharma, Inc.): the counter-case, on quality — but at materially higher volatility, 132.6% against 114.5%.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
BHVNBHVN on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
AVBPAVBP on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
BHVNBHVN on the Momentum factor, by 55 points.
Lower downside
BHVNBHVN carries the lower 1-month annualized volatility.
Analyst upside
BHVNBHVN on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | AVBP | BHVN | Note |
|---|---|---|---|
| Implied upside to target | +96.6% | +113.5% | BHVN has more room |
| Target dispersion | +46.9% | +98.3% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 11 | 17 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 5 covered evidence groups favor BHVN. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | BHVN | 35 vs 47 |
| Fundamentals | Even | revenue growth 0% vs 0%; EPS growth 22.9% vs 5.5%; TTM ROE -10.2% vs 131.6% |
| Valuation | Not covered | Not covered |
| Technicals | BHVN | Price vs 50-day -39.1% vs 2.2%; vs 200-day -50.9% vs 12.1% |
| Risk Resilience | Even | Risk Resilience 32 vs 35 |
| Analyst expectations | BHVN | Target upside 96.6% vs 113.5% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AVBP and BHVN and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is wide at 12 points. (supports the conclusion holding)
- The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
- The lead has swung materially session to session. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
- Analyst targets on the leader are widely dispersed. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BHVN.
How the comparison changed
120 daily snapshots · May 27 – Nov 13BHVN lead: Reversed — AVBP led by 5 AIQ points 30 sessions ago; BHVN now leads by 12.
- Today
- BHVN +12
- 35 vs 47
- 7 sessions ago
- BHVN +8
- 40 vs 48
- 30 sessions ago
- AVBP +5
- 41 vs 36
- 90 sessions ago
- AVBP +22
- 67 vs 45
The lead changed hands once in this window, most recently on Oct 29 when BHVN moved ahead of AVBP.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
1 bullish / 2 bearish / 1 neutral, conflicted
Only AVBP
- Death Cross Active — bearish, trend, long horizon (23.98%)
- Downtrend Structure Active — bearish, trend, long horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
3 bullish / 3 bearish / 2 neutral, conflicted
Only BHVN
- Golden Cross Active — bullish, trend, long horizon (9.68%)
- ADX Trend Weakening — neutral, trend, medium horizon
- Beta Spike Warning — bearish, risk_regime, long horizon
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.33x)
- MACD Histogram Expanding Bearish — bearish, momentum, short horizon
- Uptrend Structure Active — bullish, trend, long horizon
Both carry 1 more signal that do not separate them: ATR Expansion - Breakout Mode.
BHVN leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is down while the AIQ Score moved up 3 points over the same session — price and model disagree (price -0.46%, AIQ +3 points).
Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -1.78%, AIQ +1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1AVBP closes the Momentum gap — currently 55 points behind, the largest single contributor to BHVN's edge.
- 2AVBP's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3BHVN's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | AVBP | BHVN |
|---|---|---|
| Revenue growth (YoY) | 0% | 0% |
| EPS growth (YoY) | 22.9% | 5.5% |
| Gross margin | 100% | 0% |
| Operating margin | -36.2% | 0% |
| Return on equity (TTM) | -10.2% | 131.6% |
| Debt to equity | 0 | -3.06 |
Performance
BHVN leads 6 of 6 windows| Metric | AVBP | BHVN |
|---|---|---|
| 1 week (5 sessions) | -4.6% | -4.6% |
| 1 month (20 sessions) | -21.9% | 28.2% |
| 3 months (63 sessions) | -55.2% | -4.4% |
| 6 months (126 sessions) | -53.3% | 57.8% |
| Year to date | -35.3% | 22.4% |
| 1 year (252 sessions) | -35.6% | 73.8% |
Technicals
BHVN has the stronger structure| Metric | AVBP | BHVN |
|---|---|---|
| RSI (14) | 34.1 | 47.8 |
| ADX (14) | 31.9 | 24.5 |
| Price vs 50-day | -39.1% | 2.2% |
| Price vs 200-day | -50.9% | 12.1% |
| Volatility (1M, annualized) | 132.6% | 114.5% |
Risk
Split| Metric | AVBP | BHVN |
|---|---|---|
| Beta | 1.14 | 1.28 |
| Sharpe ratio | -0.08 | 1 |
| Sortino ratio | -0.1 | 1.74 |
| Max drawdown | -64.8% | -41.2% |
| Current drawdown | -62.6% | -18.5% |
| Annualized volatility | 81.5% | 83% |
| Value at risk (95%) | -5.3% | -6.7% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AVBP or BHVN?
On the Algovestiq AIQ Score, BHVN is the stronger of the two as of Nov 15, 2026, scoring 47 against AVBP's 35. The edge comes from momentum. AVBP is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AVBP or BHVN the better buy right now?
BHVN carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the lead has already changed hands inside the comparison window. Treat the lead as provisional.
Why does the AIQ Score favor BHVN over AVBP?
The composite weights Quality, Value, Momentum and Risk Resilience. BHVN leads Momentum by 55 points; AVBP leads Quality by 35 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AVBP or BHVN?
Analyst price targets imply +96.6% upside for AVBP and +113.5% for BHVN, so the Street currently favors BHVN. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AVBP or BHVN?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AVBP or BHVN?
AVBP on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AVBP or BHVN?
BHVN on the Momentum factor, by 55 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AVBP or BHVN?
BHVN is the more resilient of the two, so the other name carries the higher downside risk. BHVN carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AVBP more profitable than BHVN?
BHVN leads on the comparable margin measures — gross margin 100% vs 0%; operating margin -36.2% vs 0%; ttm roe -10.2% vs 131.6%.
Is BHVN's lead over AVBP getting stronger or weaker?
BHVN lead: Reversed — AVBP led by 5 AIQ points 30 sessions ago; BHVN now leads by 12. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-10-29, when BHVN moved ahead of AVBP.
What would change the AVBP vs BHVN verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AVBP closes the Momentum gap — currently 55 points behind, the largest single contributor to BHVN's edge; AVBP's Death Cross Active resolves — a bearish trend rule currently active against it; BHVN's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about AVBP and BHVN?
AVBP: 1 bullish / 2 bearish / 1 neutral, conflicted. BHVN: 3 bullish / 3 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AVBP is Death Cross Active (bearish, long horizon). On BHVN it is Golden Cross Active (bullish, long horizon).
Compare AVBP and BHVN with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.